European Investment Bank (EIB) Extends Financing Agreement to €24 Million Total in Support of BiondVax’s Universal Flu Vaccine Ongoing Pivotal Phase 3 Clinical Trial
“JERUSALEM, April 22, 2019 /PRNewswire/ — BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), announced today that the Management Committee of the European Investment Bank (EIB) agreed to [...]
